DalsnaFinance › IPOs › Entrada Therapeutics Inc › IPO
Entrada Therapeutics, Inc. completed its initial public offering on NASDAQ on October 29, 2021, pricing at $20.00 a share.
| Ticker | TRDA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 29, 2021 |
| Offering price | $20.00 |
| Shares offered | 9,075,000 |
| Total raised | $182M |
Entrada Therapeutics, Inc. sold 9,075,000 shares at $20.00 each on NASDAQ. Multiplied out, that is $181.5 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $182 million total recorded for the deal.
Entrada Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Entrada Therapeutics, Inc.. This page is general information, not investment advice.